and is believed to encode a penicillinsensitive DD-carboxypeptidase. The enzyme activity was found to be membrane-bound and inhibited by low concentrations of benzylpenicillin in membrane preparations and in intact bacteria, indicating that the active site was present on the outside surface of the membrane. The 38 kDa protein was revealed as a PBP present in more copies per cell than conventional PBPs and all the protein was accessible to benzylpenicillin added externally, confirming the localization of the active site. A glycopeptide-susceptible strain of E. faecium lacked this PBP, and the membrane-bound DD-carboxypeptidase activity was less than 5 % of that of E. faecium BM4339. Although the active site of VanY D was external to the membrane, UDP-MurNAc-tetrapeptide was produced internally, probably from UDP-MurNAc-pentadepsipeptide. The presence of benzylpenicillin at low concentrations in the growth medium substantially reduced the amount of tetrapeptide produced, indicating that inhibition of VanY D by benzylpenicillin influenced production of peptidoglycan precursors internally. A model to explain these contrasting observations is proposed.
INTRODUCTION
Glycopeptide antibiotics interfere with the last steps of peptidoglycan synthesis in Gram-positive bacteria (Nagarajan, 1991) . These large molecules, which cannot penetrate the cytoplasmic membrane, form complexes with the C-terminal -alanyl--alanine (-Ala--Ala) of late peptidoglycan precursors when they are transported to the external side of the membrane (Reynolds, 1989) . As a result, peptidoglycan precursors can no longer be incorporated into nascent peptidoglycan through the transglycosylation and the transpeptidation reactions. Release of the C-terminal -Ala residue from pentapeptides, catalysed by penicillin-binding proteins (PBPs) displaying transpeptidase or -carboxypeptidase activity, is also inhibited (Arthur et al., 1996) . Enterococci with acquired VanA-, VanB-or VanD-type resistance to glycopeptides synthezise modified peptidoglycan precursors, ending in the depsipeptide -alanyl--lactate (-Ala--Lac) instead of the dipeptide -Ala--Ala (Arthur et al., 1996) . These modified precursors exhibit a 1000-fold reduced affinity for vancomycin (Bugg et al., 1991) . VanD-type resistance to glycopeptides in enterococci is mediated by the chromosomal vanD gene cluster, which includes at least six open reading frames (Casadewall & Courvalin, 1999 ; Pe! richon et al., 2000) . The 5h region of the vanD operon contains the vanR D and vanS D genes encoding a two-component regulatory system. The vanY D gene, located downstream, encodes a -carboxypeptidase related to PBPs (Casadewall & Courvalin, 1999) . The 3h part of the vanD gene cluster includes the vanH D , vanD and vanX D genes, which encode a -Lac dehydrogenase, a -Ala : -Lac ligase and a -dipeptidase, respectively. These proteins are homologous to the corresponding enzymes in VanAand VanB-type strains. VanD-type Enterococcus faecium BM4339 is constitutively resistant to moderate levels of vancomycin (MIC 64 µg ml −" ) and to low levels of teicoplanin (MIC 4 µg ml −" ) (Pe! richon et al., 1997) . In this strain, the vanD gene cluster contains, at the 3h end, the intD gene, which encodes an integrase-like protein (Casadewall et al., 2001) . The vanY D gene is co-transcribed with vanH D , vanD, vanX D and intD from the P YD promoter, whereas the vanR D and vanS D genes are expressed from the P RD promoter (Casadewall et al., 2001 ). Due to a frameshift mutation in the chromosomal ddl gene (Casadewall & Courvalin, 1999) , E. faecium BM4339 produces an impaired -Ala : -Ala ligase (Ddl), accounting for the lack of -Ala--Ala-terminating peptidoglycan precursors in this strain (Pe! richon et al., 1997) . VanY D -carboxypeptidase belongs to the PBP family of catalytic-serine enzymes which are susceptible to benzylpenicillin (Joris et al., 1988) , whereas VanY and VanY B from VanA-and VanB-type strains are penicillininsensitive Zn# + -dependent proteins (Arthur et al., 1998 ; Wright et al., 1992) . In glycopeptide-resistant enterococci, both types of membrane-bound enzymes hydrolyse pentapeptide and\or pentadepsipeptide peptidoglycan precursors to tetrapeptides, but their catalytic efficiency depends on the substrate. Although some of the PBPs which function as -carboxypeptidases preferentially cleave depsipeptide substrates (Rasmussen & Strominger, 1978) , the Zn# + -dependent VanY -carboxypeptidase exhibits a higher catalytic efficiency for hydrolysis of substrates ending in -Ala--Ala (Arthur et al., 1998) . VanY B has been shown to play a more important role in VanB-type resistance than VanY in VanA-type resistance (Reynolds, 1998) . VanY B contributes to resistance by hydrolysing pentapeptide precursors rapidly after induction by vancomycin, whereas, in VanA-type strains, the high -Ala--Ala dipeptidase activity of VanX is sufficient for resistance (Arthur et al., 1994 
METHODS
Strains and growth conditions. Glycopeptide-resistant E. faecium BM4339 (Pe! richon et al., 1997) and glycopeptidesusceptible E. faecium ATCC 9790 were grown in brain heart infusion (BHI) broth or on BHI agar supplemented with yeast extract (0n5%, w\v) (BHY). Small culture volumes were incubated overnight at 30 mC. The cultures were diluted in BHY broth to an OD '!! less than 0n1 and incubated in an orbital incubator (100 r.p.m.) at 37 mC. Cultures were used in the exponential phase of growth (OD '!! 0n8-1n0). The MICs of antibiotics were determined using twofold dilutions of the antibiotics in BHY broth with an inoculum of 10' bacteria ml − ". Tubes were incubated for 24 h at 37 mC. Analysis of precursors. Extraction and analysis of soluble peptidoglycan precursors were carried out essentially as described previously (Arthur et al., 1998) . Ramoplanin was used at a final concentration of 3 µg ml − " for 15 min to eliminate possible damage to the cytoplasmic membrane during accumulation of the precursors. After extraction with trichloroacetic acid and desalting on Sephadex G10, HPLC was used to separate the late peptidoglycan precursors and the relative amounts were determined from the integrated peak areas (Arthur et al., 1998) . Preparation of membrane fragments. A 20 ml culture at an OD '!! of 1n0 was centrifuged (25 000 g, 30 s), the pellet washed once in 50 mM Tris\HCl pH 7n2 and the cells resuspended in 0n9 ml of the same buffer. Then 100 µl lysozyme (4 mg ml − ") and 70 µl M1 muramidase (1 mg ml − ") were added and the mixture incubated at 37 mC until osmotic lysis was complete as judged by clearing of the suspension and phase-contrast microscopy. DNase (25 µg ml − ") and MgCl # (5 mM) were added and incubation continued for 3 min at 37 mC. The suspension was cooled to 4 mC and the membrane fraction collected by centrifugation at 48 000 g for 20 min. The pellet was washed in 50 mM Tris\HCl pH 7n2 and finally resuspended in the same buffer.
Binding of benzyl[

14
C]penicillin
Membrane labelling. Ten microlitres of a membrane suspension (5 mg protein ml − ") was incubated for 5 min at 37 mC with 2 µl of different concentrations of benzyl["%C]penicillin (53 mCi mmol − " ; 1961 MBq mmol − "). Then 2 µl unlabelled penicillin (3 mg ml − ") was added and membrane proteins were solubilized by heating for 4 min at 98 mC after addition of Sample Buffer (New England Biolabs). The proteins were separated by SDS-PAGE on a 12 % polyacrylamide gel using the Laemmli buffer system (Laemmli, 1970) .The gel was stained with 0n1 % Coomassie blue in 50 % (v\v) methanol\10 % (v\v) acetic acid for 30 min at 37 mC, destained with 10 % (v\v) methanol\10 % (v\v) acetic acid for 1 h at 37 mC and dried on 3 MM paper using a Hoefer slab gel drier. PBPs were detected and the amounts of the 40-42 kDa penicilloyl-protein complex determined using a phosphorimager (Molecular Dynamics, model 425). Autoradiography on Kodak X-Omat film was carried out for 4 weeks to reveal minor PBPs. Penicillin-sensitive VanY D -carboxypeptidase unlabelled benzylpenicillin (2 mg ml − ") and lysed by treatment with lysozyme (400 µg ml − ") and M1 muramidase (70 µg ml − "). Membranes were pelleted by centrifugation (48 000 g, 20 min), washed once and resuspended in 10 µl 50 mM Tris\HCl pH 7n2. Membrane proteins were separated and PBPs determined as described above. Accessibility of DD-carboxypeptidase in intact bacteria. Bacteria were harvested, washed once and resuspended at 2 mg dry wt ml − " in 50 mM Tris\HCl pH 7n2. Aliquots (0n5 ml) were incubated with benzylpenicillin (1, 0n1 and 0n01 µg ml − ") for 5 min at 37 mC, a large excess of β-lactamase (Neutrapen, Riker laboratories), 20 000 units, was added and incubation continued for 1 min at 37 mC. The samples were diluted with 5 ml 50 mM Tris\HCl pH 7n2 at 4 mC and the bacteria harvested by centrifugation at 25 000 g for 30 s. The pellet was resuspended in 5 ml of the same buffer and the centrifugation stage repeated. The bacterial pellet was resuspended in 0n5 ml Tris\HCl pH 7n2 containing lysozyme (200 µg) and M1 muramidase (35 µg) and incubated at 37 mC until lysis was complete (15 min). DNase (25 µg ml − ") and 5 mM MgCl # were added and incubation continued for 3 min. The membrane suspension was cooled to 4 mC and the membranes collected by centrifugation at 48 000 g for 20 min. The pellets were resuspended in 250 µl 50 mM Tris\HCl pH 7n2 and -carboxypeptidase activity determined using 10 µl samples in duplicate.
Assay of DD-carboxypeptidase activity
Determination of D-Ala released. This was carried out essentially as described previously (Messer & Reynolds, 1992) . A membrane preparation (10 µl, 0n8 mg protein ml − ") was incubated in 50 mM Tris\HCl pH 7n2 with 10 mM pentapeptide for 30 min at 37 mC. -Ala released from the substrate was determined using -amino acid oxidase with o-dianisidine as the chromogen. Determination of UDP-MurNAc-tetrapeptide. A membrane preparation (10 µl, 2 mg protein ml − ") was incubated in 50 mM Tris\HCl pH 7n2 with 3n5 mM pentapeptide or pentadepsipeptide for 30 min at 37 mC. Proteins were removed by treatment with 5-sulphosalicylic acid, the supernatant diluted 35-fold to give a 100 µM solution of nucleotide precursors and the tetrapeptide product separated from the substrate by HPLC (Reynolds et al., 1999) .
RESULTS
Glycopeptide resistance and penicillin action
E. faecium BM4339, in common with other E. faecium strains, was resistant to benzylpenicillin, with an MIC of 128 µg ml −" . It does not produce a β-lactamase, indicating that a PBP vital for peptidoglycan metabolism was not saturated at this antibiotic concentration. The MIC of vancomycin was 64 µg ml −" . However, the two antibiotics acted synergistically and no growth occurred when benzylpenicillin was present at 2 µg ml −" and vancomycin at 8 µg ml −" . This observation implicated a penicillin-binding protein in the glycopeptide resistance mechanism of E. faecium BM4339. Synergism between penicillins and glycopeptides has already been observed in VanA-type enterococci and was accounted for by processing of -Ala--Lac-ending precursors by a conventional PBP with high affinity for β-lactams (Gutmann et al., 1994) .
Effect of growth in the presence of benzylpenicillin on peptidoglycan precursors
UDP-MurNAc--Ala--Glu--Lys--Ala (tetrapeptide) is present in the cytoplasm of E. faecium BM4339 after a 15 min incubation with ramoplanin, which inhibits the transfer of GlcNAc from UDP-GlcNAc to C-55 undecaprenyl-P-P-MurNAc(pentapeptide) (lipid I) to produce lipid II (Somner & Reynolds, 1990) . The -carboxypeptidase activity believed to be catalysed by VanY D is inhibited by benzylpenicillin (Pe! richon et al., 1997) . If this enzyme is involved in the production of tetrapeptide in the cytoplasm, growth of E. faecium BM4339 in the presence of penicillin G followed by analysis of the precursors would be expected to result in a reduction of the amount of tetrapeptide produced. Low concentrations of benzylpenicillin in the growth medium caused the predicted reduction in tetrapeptide (Table 1 ). The effect of benzylpenicillin was more marked in E. faecium BM4458 [BM4339 : :
. This strain synthesizes pentapeptide and pentadepsipeptide precursors, but both the amount and percentage of pentapeptide increased substantially when benzylpenicillin (1 µg ml −" ) was included in the growth medium ( Table 1 ), indicating that it was almost totally hydrolysed when VanY D was active.
Analysis of PBPs of E. faecium BM4339 and glycopeptide-susceptible E. faecium ATCC 9790
Incubation of a membrane preparation with various concentrations of benzyl["%C]penicillin indicated that E. faecium BM4339 contained a PBP which migrated as a 
doublet on SDS gels with an apparent molecular mass of 40-42 kDa. The protein was more heavily labelled than the normal complement of high-and low-M r PBPs involved in peptidoglycan metabolism and was saturated at low concentrations of benzylpenicillin (Fig. 1) . The 40-42 kDa PBP was absent from membranes of E. faecium ATCC 9790 (Fig. 2) . The protein was accessible to benzyl["%C]penicillin at low concentrations in intact bacteria and the 50 % saturation level was similar to that obtained with binding to membrane preparations (Table  2 ). The penicilloyl-protein bond was stable but in a 4 h incubation at 37 mC the complex was degraded to a 32 kDa penicilloylpeptide that was no longer membrane bound, indicating that the membrane-spanning domain had been removed (result not shown). Previous growth of the bacteria in the presence of unlabelled benzylpenicillin (3 µg ml −" ) completely saturated the 40-42 kDa PBP, as rigorous washing of the bacteria followed by preparation of the membrane fraction and incubation with benzyl["%C]penicillin (10 µg ml −" ) resulted in less than 1 % radioactivity bound to the protein relative to that in the control preparation obtained from bacteria grown in the absence of benzylpenicillin.
Inhibition of DD-carboxypeptidase activity by benzylpenicillin
The -carboxypeptidase activity in membrane preparations of E. faecium BM4339 was inhibited by low concentrations of benzylpenicillin with an ID &! of approximately 0n02 µg ml −" (Table 3) . To investigate whether the activity was also inhibited by benzylpenicillin in intact bacteria, a washed suspension of E. faecium BM4339 was treated with different concentrations of the antibiotic followed by removal of unbound benzylpenicillin with β-lactamase and extensive washing prior to osmotic lysis of the bacteria and assay of -carboxypeptidase activity in the resultant membrane preparation. The activity was inhibited at concentrations of benzylpenicillin similar to those that completely inhibited the enzyme in membrane preparations (Table 3) . A control to investigate the breakdown of the -carboxypeptidase-penicillin complex at 37 mC demonstrated that no activity was regained in the time taken to lyse the bacteria osmotically prior to recovery and washing of the membrane preparation. In a further control, membrane preparations from two glycopeptidesusceptible strains of E. faecium were assayed for -carboxypeptidase activity at the same concentration of membrane protein : less than 5 % of the -carboxypeptidase activity of membranes from E. faecium BM4339 was present, indicating that the normal low-M r PBPs of E. faecium BM4339 would not have contributed significantly to the release of -Ala under the conditions of the experiment.
Substrate specificity of VanY D DD-carboxypeptidase
The substrate specificity of membrane-bound VanY D was investigated by following production of tetrapeptide from UDP-MurNAc--Ala--Glu--Lys--Ala--Ala (pentapeptide) or UDP-MurNAc--Ala--Glu--Lys--Ala--Lac (pentadepsipeptide) by HPLC. The activity of a membrane preparation of E. faecium BM4339 was more than threefold greater against pentapeptide than pentadepsipeptide and both activities were inhibited by benzylpenicillin (Table 4) . The -carboxypeptidase activity of a membrane preparation of glycopeptidesusceptible E. faecium ATCC 9790 against pentapeptide was not detectable under the same conditions although low penicillin-susceptible activity was detected with pentadepsipeptide as substrate (Table 4) .
DISCUSSION
Vancomycin resistance is expressed constitutively in E. faecium BM4339. A mutation in the ddl gene results in a defective -Ala : -Ala ligase and the consequent absence of peptidoglycan precursors ending in -Ala--Ala. The constitutive phenotype could be due to a mutation in the vanS D gene (Casadewall & Courvalin, 1999) or to the activity of a different protein kinase able to upregulate expression of the vanD gene cluster (Casadewall et al., 2001) . The majority of E. faecium isolates grow in high concentrations of benzylpenicillin because the vital target of penicillin is a PBP with low affinity. However, growth of E. faecium BM4339 in the presence of subinhibitory concentrations of benzylpenicillin resulted in a substantial decrease of the vancomycin MIC, indicating that a penicillin-sensitive reaction was likely to be involved in glycopeptide resistance of this strain. The percentages of peptidoglycan precursors in the cytoplasm were also altered as a result of growth of BM4339 or BM4458 [BM4339 : : pAT665(P # ddl)] in the presence of benzylpenicillin, with a marked reduction in the amount of tetrapeptide present. This compound is produced as the result of -carboxypeptidase activity on pentapeptide or pentadepsipeptide precursors. These observations suggested that the active site of the penicillin-sensitive -carboxypeptidase was external to the cytoplasmic membrane because bacteria have been shown to be impermeable to benzylpenicillin (Cooper, 1956 ), but, in contrast, inhibition of its activity affected peptidoglycan precursors produced internally.
The location of the active site of VanY D , the putative -carboxypeptidase, was investigated by two methods : binding of benzyl["%C]penicillin to intact bacteria and membrane preparations, and secondly, measurement of enzyme activity in membrane preparations after treatment of membranes or intact bacteria with benzylpenicillin. The PBP profile of membrane proteins in VanD E. faecium BM4339, but not the amounts of individual PBPs, was virtually identical to that of the glycopeptide-susceptible E. faecium ATCC 9790, with the exception that a heavily labelled protein doublet was also present with a mass of 40-42 kDa, lower than that of any of the conventional PBPs of E. faecium isolates. The 40-42 kDa protein was saturated at a benzyl["%C]penicillin concentration of 1n0 µg ml −" both in membrane preparations, where binding could have occurred from either or both sides of the membrane, and after binding to intact bacteria, in which benzylpenicillin should bind only to active sites exposed on the outside surface of the cytoplasmic membrane. The lack of binding of benzyl["%C]penicillin to the 40-42 kDa protein in membranes prepared from intact bacteria that had been grown in the presence of benzylpenicillin indicated that all the active sites of the protein were accessible to benzylpenicillin on the outside surface of the membrane. The amount of the 40-42 kDa PBP, as judged by the amount of bound radiolabel, was severalfold greater than the amount of any of the PBPs common to both glycopeptide-susceptible and -resistant strains, consistent with the probability that this PBP is VanY D and possesses -carboxypeptidase activity. The calculated M r of VanY D is 38 685, smaller than that obtained by comparison of the rate of migration in SDS gels with those of standard proteins, but such measurements can lead to anomalous values. There was a reasonable correspondence between the concentrations of benzylpenicillin that bound to the 40-42 kDa protein and those that inhibited -carboxypeptidase activity. Although the concentration of active benzylpenicillin in the radiolabelled preparation was assumed to be 100 % of the value calculated on the basis of specific activity, freezing and thawing of the preparation over the course of several weeks would probably have resulted in some breakdown of the antibiotic, which would have affected the values given in Table 2 . If breakdown had occurred, the correspondence between the two sets of data in Tables 2 and 3 may have been closer than those obtained. Furthermore the enzyme activity of membranes prepared from bacteria that had been pretreated with benzylpenicillin prior to lysis and collection of the membrane fragments for assay was inhibited at concentrations similar to those that inhibited the activity when membranes were exposed directly to benzylpenicillin, confirming that the active site was external to the cytoplasmic membrane. In strains expressing the VanA and VanB phenotypes it had previously been concluded that the presence of tetrapeptide peptidoglycan precursors in the cytoplasm resulted from the activity of membrane-bound VanY or VanY B in which the active site was inside the cytoplasmic membrane, although the substrate was most likely to be a lipid intermediate carrying the peptidoglycan subunit (Arthur et al., 1998) .
The hydrophobicity profile of VanY D suggests that, in common with high-M r PBPs, there is a single transmembrane segment close to the N-terminus. The penicillin-binding studies established that the tetrad motif SXXK containing the active-site serine is present external to the cytoplasmic membrane. This implies that the complete C-terminal domain of the protein that contains all the characteristic signatures of a PBP is present on the external face of the membrane.
Comparison of the -carboxypeptidase activities of membranes prepared from E. faecium BM4339 and from E. faecium ATCC 9790 provides strong evidence that the -carboxypeptidase activities measured in these investigations were catalysed by VanY D and not by another PBP. No -carboxypeptidase activity against pentapeptide was detected in the membranes of E. faecium ATCC 9790 by HPLC under the experimental conditions but a low level of activity against pentadepsipeptide was present, in agreement with the observations of Rasmussen & Strominger (1978) that PBPs may have greater activity against esters than peptides. Membranes containing VanY D possessed greater activity against pentapeptide than against pentadepsipeptide. Furthermore, a proportion of the activity against the latter substrate may have resulted from the activity of normal PBPs. In this respect, i.e. lower activity against esters than peptides, VanY D may differ from the classical PBPs though there is no obvious explanation for this difference. The fact that VanY D removes the terminal residue from both pentapeptide and pentadepsipeptide suggests that the tetrapeptide present in the cytoplasm following a short incubation with ramoplanin could have arisen from both precursors, though the amount of pentapeptide available as a substrate is likely to be small in view of the absence of an active -Ala : -Ala ligase. The small amount of pentapeptide present after growth of E. faecium BM4339 in the presence of benzylpenicillin could have resulted from the -Ala : -Ala ligase activity of VanD, which is assumed primarily to function as a -Ala : -Lac ligase (Casadewall & Courvalin, 1999) . Studies with BM4458 [BM4339 : : pAT665(P # ddl)] confirmed that VanY D hydrolysed pentapeptide rapidly ; the concentration of the precursor in the cytoplasm was reduced sixfold when the enzyme was active (Table 1 ).
It is difficult to explain how tetrapeptide, the product of the -carboxypeptidase reaction, is present inside the cell when the active site of the enzyme is on the outside surface of the cytoplasmic membrane. The peptidoglycan precursors were analysed after a 15 min incubation of the bacteria with ramoplanin (three times the MIC), which inhibits the conversion of lipid I to lipid II. As a result of the inhibition all the undecaprenyl lipid derivatives would be in the form of lipid I. The reaction in which P-MurNAc-pentapeptide is added to undecaprenyl lipid-P is reversible and the position of equilibrium in a non-dynamic situation favours the reverse reaction in which the nucleotide peptidoglycan precursor would be re-formed. If lipid I containing MurNAc-pentapeptide, when present in excess, could cross the membrane to the outside face (as does lipid II for peptidoglycan biosynthesis) it could be acted on by the VanY D -carboxypeptidase to generate lipid I containing a tetrapeptide ; the results suggest that this may be able to re-cross the membrane to the cytoplasm, where it could be acted on by UMP pyrophosphorylase to produce the tetrapeptide derivative (Fig. 3) .
The location of vanY D in the vancomycin-resistance operon presumably ensures high levels of vancomycin resistance in VanD strains that may not have a defective -Ala : -Ala ligase. Consequently it is unlikely to be involved in normal aspects of peptidoglycan metabolism, including control of the level of cross-linking and\or recycling of peptidoglycan degradation products. The location of the active site on the outside surface of the cytoplasmic membrane suggests that [vanH, vanA(B,D), vanX] . This evolutionary diversity in arriving at the same solution in solving a problem highlights the ability of bacteria to adapt to potentially lethal situations in different ways.
